Prodigiosin as an antibiofilm agent against multidrug-resistant Staphylococcus aureus

References

• Abdelfattah MS, Elmallah MIY, Ebrahim HY, Almeer RS, Eltanany RMA, Abdel Moneim AE. 2019. Prodigiosins from a marine sponge-associated actinomycete attenuate HCl/ethanol-induced gastric lesion via antioxidant and anti-inflammatory mechanisms. PLoS One. 14:e0216737. doi: 10.1371/journal.pone.0216737.
   PubMed Web of Science ®Google Scholar
• Akya A, Chegenelorestani R, Shahvaisi-Zadeh J, Bozorgomid A. 2020. Antimicrobial resistance of Staphylococcus aureus isolated from hospital wastewater in Kermanshah, Iran. Risk Manag Healthc Policy. 13:1035–1042. doi: 10.2147/RMHP.S261311.
   PubMed Web of Science ®Google Scholar
• Albrakati A, Alsharif KF, Al Omairi NE, Alsanie WF, Almalki ASA, Abd Elmageed ZY, Elshopakey GE, Lokman MS, Bauomy AA, Abdel Moneim AE, et al. 2021. Neuroprotective efficiency of prodigiosins conjugated with selenium nanoparticles in rats exposed to chronic unpredictable mild stress is mediated through antioxidative, anti-inflammatory, anti-apoptotic, and neuromodulatory activities. Int J Nanomedicine. 16:8447–8464. doi: 10.2147/IJN.S323436.
   PubMed Web of Science ®Google Scholar
• Anwar MM, Shalaby M, Embaby AM, Saeed H, Agwa MM, Hussein A. 2020. Prodigiosin/PU-H71 as a novel potential combined therapy for triple negative breast cancer (TNBC): preclinical insights. Sci Rep. 10:14706. doi: 10.1038/s41598-020-71157-w.
   PubMed Web of Science ®Google Scholar
• Arivizhivendhan KV, Mahesh M, Boopathy R, Swarnalatha S, Regina Mary R, Sekaran G. 2018. Antioxidant and antimicrobial activity of bioactive prodigiosin produces from Serratia marcescens using agricultural waste as a substrate. J Food Sci Technol. 55:2661–2670. doi: 10.1007/s13197-018-3188-9.
   PubMed Web of Science ®Google Scholar
• Bouchelaghem S, Das S, Naorem RS, Czuni L, Papp G, Kocsis M. 2022. Evaluation of total phenolic and flavonoid contents, antibacterial and antibiofilm activities of hungarian propolis ethanolic extract against Staphylococcus aureus. Molecules. 27:574. doi: 10.3390/molecules27020574.
   PubMed Web of Science ®Google Scholar
• Brennan AA, Mehrani M, Tal-Gan Y. 2022. Modulating streptococcal phenotypes using signal peptide analogues. Open Biol. 12:220143. doi: 10.1098/rsob.220143.
   PubMed Web of Science ®Google Scholar
• Bujňáková D, Čuvalová A, Čížek M, Humenik F, Salzet M, Čížková D. 2020. Canine bone marrow mesenchymal stem cell conditioned media affect bacterial growth, biofilm-associated Staphylococcus aureus and AHL-dependent quorum sensing. Microorganisms. 8:1478. doi: 10.3390/microorganisms8101478.
   PubMed Web of Science ®Google Scholar
• Castro AJ. 1967. Antimalarial activity of prodigiosin. Nature. 213:903–904. doi: 10.1038/213903a0.
   PubMed Web of Science ®Google Scholar
• CLSI. 2018. Performance standards for antimicrobial susceptibility testing; twenty-eight informat. Supplement - M100-S28.
   Google Scholar
• Cuevas A, Saavedra N, Salazar LA, Cavalcante MF, Silva JC, Abdalla DSP. 2020. Prodigiosin modulates the immune response and could promote a stable Atherosclerotic lession in C57bl/6 Ldlr-/- mice. IJMS. 21:6417. doi: 10.3390/ijms21176417.
   Google Scholar
• Darshan N, Manonmani HK. 2016. Prodigiosin inhibits motility and activates bacterial cell death revealing molecular biomarkers of programmed cell death. AMB Express. 6:50. doi: 10.1186/s13568-016-0222-z.
   PubMed Web of Science ®Google Scholar
• Davient B, Ng JPZ, Xiao Q, Li L, Yang L. 2018. Comparative transcriptomics unravels prodigiosin’s potential cancer-specific activity between human small airway epithelial cells and lung adenocarcinoma cells. Front Oncol. 8:573. doi: 10.3389/fonc.2018.00573.
   PubMed Web of Science ®Google Scholar
• Fernando SA, Gray TJ, Gottlieb T. 2017. Healthcare-acquired infections: prevention strategies. Intern Med J. 47:1341–1351. doi: 10.1111/imj.13642.
   PubMed Web of Science ®Google Scholar
• Gerber NN. 1975. A new prodiginne (prodigiosin-like) pigment from Streptomyces. antimalarial activity of several prodiginnes. J Antibiot (Tokyo). 28:194–199. doi: 10.7164/antibiotics.28.194.
   PubMed Web of Science ®Google Scholar
• Girijan SK, Pillai D. 2021. Identification and characterization of vancomycin-resistant Staphylococcus aureus in hospital wastewaters: evidence of horizontal spread of antimicrobial resistance. J Water Health. 19:785–795. doi: 10.2166/wh.2021.117.
   PubMed Web of Science ®Google Scholar
• Gohil N, Bhattacharjee G, Singh V. 2020. Synergistic bactericidal profiling of prodigiosin extracted from Serratia marcescens in combination with antibiotics against pathogenic bacteria. Microb Pathog. 149:104508. doi: 10.1016/j.micpath.2020.104508.
   PubMed Web of Science ®Google Scholar
• Han S-B, Lee CW, Yoon YD, Kang JS, Lee KH, Yoon WK, Kim YK, Lee K, Park S-K, Kim HM. 2005. Effective prevention of lethal acute graft-versus-host disease by combined immunosuppressive therapy with prodigiosin and cyclosporine A. Biochem Pharmacol. 70:1518–1526. doi: 10.1016/j.bcp.2005.08.017.
   PubMed Web of Science ®Google Scholar
• Herráez R, Quesada R, Dahdah N, Viñas M, Vinuesa T. 2021. Tambjamines and prodiginines: biocidal activity against Trypanosoma cruzi. Pharmaceutics. 13:705. doi: 10.3390/pharmaceutics13050705.
   PubMed Web of Science ®Google Scholar
• Heydorn A, Nielsen AT, Hentzer M, Sternberg C, Givskov M, Ersbøll BK, Molin SY. 2000. Quantification of biofilm structures by the novel computer program comstat. Microbiology. 146:2395–2407. doi: 10.1099/00221287-146-10-2395.
   PubMed Web of Science ®Google Scholar
• Idrees M, Sawant S, Karodia N, Rahman A. 2021. Staphylococcus aureus Biofilm: morphology, genetics, pathogenesis and treatment strategies. IJERPH. 18:7602. doi: 10.3390/ijerph18147602.
   Web of Science ®Google Scholar
• Jamal M, Ahmad W, Andleeb S, Jalil F, Imran M, Nawaz MA, Hussain T, Ali M, Rafiq M, Kamil MA. 2018. Bacterial biofilm and associated infections. J Chin Med Assoc. 81:7–11. doi: 10.1016/j.jcma.2017.07.012.
   PubMed Web of Science ®Google Scholar
• Jenul C, Horswill AR. 2019. Regulation of Staphylococcus aureus virulence. Microbiol Spectr. 7: doi: 10.1128/microbiolspec.GPP3-0031-2018.
   PubMed Web of Science ®Google Scholar
• Kancharla P, Li Y, Yeluguri M, Dodean RA, Reynolds KA, Kelly JX. 2021. Total Synthesis and antimalarial activity of 2-(p-Hydroxybenzyl)-prodigiosins, isoheptylprodigiosin, and geometric isomers of Tambjamine MYP1 isolated from marine bacteria. J Med Chem. 64:8739–8754. doi: 10.1021/acs.jmedchem.1c00748.
   PubMed Web of Science ®Google Scholar
• Karuppiah V, Seralathan M. 2022. Quorum sensing inhibitory potential of vaccenic acid against Chromobacterium violaceum and methicillin-resistant Staphylococcus aureus. World J Microbiol Biotechnol. 38:146. doi: 10.1007/s11274-022-03335-z.
   PubMed Web of Science ®Google Scholar
• Kimyon Ö, Das T, Ibugo AI, Kutty SK, Ho KK, Tebben J, Kumar N, Manefield M. 2016. Serratia secondary metabolite prodigiosin inhibits pseudomonas aeruginosa biofilm development by producing reactive oxygen species that damage biological molecules. Front Microbiol. 7:972. doi: 10.3389/fmicb.2016.00972.
   PubMed Web of Science ®Google Scholar
• Kozajda A, Jeżak K, Kapsa A. 2019. Airborne Staphylococcus aureus in different environments—a review. Environ Sci Pollut Res Int. 26:34741–34753. doi: 10.1007/s11356-019-06557-1.
   PubMed Web of Science ®Google Scholar
• Lapenda JC, Silva PA, Vicalvi MC, Sena KXFR, Nascimento SC. 2015. Antimicrobial activity of prodigiosin isolated from Serratia marcescens UFPEDA 398. World J Microbiol Biotechnol. 31:399–406. doi: 10.1007/s11274-014-1793-y.
   PubMed Web of Science ®Google Scholar
• Liu J-Y, Dickter JK. 2020. Nosocomial infections: a history of hospital-acquired infections. Gastrointest Endosc Clin N Am. 30:637–652. doi: 10.1016/j.giec.2020.06.001.
   PubMedGoogle Scholar
• Liu Y, Qiu Y, Yin Q, Li X, Bai Q, Li Y, Xiao H. 2021. iTRAQ-based quantitative proteomic reveals proteomic changes in Serratia sp. CM01 and mechanism of Cr(VI) resistance. Ecotoxicol Environ Saf. 228:112899. doi: 10.1016/j.ecoenv.2021.112899.
   PubMed Web of Science ®Google Scholar
• Mandal SM, Ghosh AK, Pati BR. 2015. Dissemination of antibiotic resistance in methicillin-resistant Staphylococcus aureus and vancomycin-resistant S aureus strains isolated from hospital effluents. Am J Infect Control. 43:e87–e88. doi: 10.1016/j.ajic.2015.08.015.
   PubMed Web of Science ®Google Scholar
• Marbach H, Mayer K, Vogl C, Lee JYH, Monk IR, Sordelli DO, Buzzola FR, Ehling-Schulz M, Grunert T. 2019. Within-host evolution of bovine Staphylococcus aureus selects for a SigB-deficient pathotype characterized by reduced virulence but enhanced proteolytic activity and biofilm formation. Sci Rep. 9:13479. doi: 10.1038/s41598-019-49981-6.
   PubMed Web of Science ®Google Scholar
• Marchal E, Smithen DA, Uddin MI, Robertson AW, Jakeman DL, Mollard V, Goodman CD, MacDougall KS, McFarland SA, McFadden GI, et al. 2014. Synthesis and antimalarial activity of prodigiosenes. Org Biomol Chem. 12:4132–4142. doi: 10.1039/c3ob42548g.
   PubMed Web of Science ®Google Scholar
• McCarthy H, Rudkin JK, Black NS, Gallagher L, O'Neill E, O'Gara JP. 2015. Methicillin resistance and the biofilm phenotype in Staphylococcus aureus. Front Cell Infect Microbiol. 5:1. doi: 10.3389/fcimb.2015.00001.
   PubMed Web of Science ®Google Scholar
• Mesrati I, Saidani M, Jemili M, Ferjeni S, Slim A, Boubaker IB-B. 2018. Virulence determinants, biofilm production and antimicrobial susceptibility in Staphylococcus aureus causing device-associated infections in a Tunisian hospital. Int J Antimicrob Agents. 52:922–929. doi: 10.1016/j.ijantimicag.2018.05.004.
   PubMed Web of Science ®Google Scholar
• Mirzaeinia S, Zeinali S, Budisa N, Karbalaei-Heidari HR. 2022. Targeted codelivery of prodigiosin and simvastatin using Smart BioMOF: functionalization by recombinant anti-VEGFR1 scFv. Front Bioeng Biotechnol. 10:866275. doi: 10.3389/fbioe.2022.866275.
   PubMed Web of Science ®Google Scholar
• Mitchell G, Fugère A, Pépin Gaudreau K, Brouillette E, Frost EH, Cantin AM, Malouin F. 2013. SigB is a dominant regulator of virulence in Staphylococcus aureus small-colony variants. PLoS One. 8:e65018. doi: 10.1371/journal.pone.0065018.
   PubMed Web of Science ®Google Scholar
• Monegro AF, Muppidi V, Regunath H. 2022. Hospital acquired infections StatPearls. Treasure Island (FL): StatPearls Publishing.
   Google Scholar
• Moormeier DE, Bayles KW. 2017. Staphylococcus aureus biofilm: a complex developmental organism. Mol Microbiol. 104:365–376. doi: 10.1111/mmi.13634.
   PubMed Web of Science ®Google Scholar
• Nguyen SLT, Nguyen TC, Do TT, Vu TL, Nguyen TT, Do TT, Nguyen THT, Le TH, Trinh DK, Nguyen TAT. 2022. Study on the anticancer activity of prodigiosin from variants of serratia marcescens QBN VTCC 910026. Biomed Res Int. 2022:4053074. doi: 10.1155/2022/4053074.
   PubMed Web of Science ®Google Scholar
• Opperman TJ, Kwasny SM, Williams JD, Khan AR, Peet NP, Moir DT, Bowlin TL. 2009. Aryl rhodanines specifically inhibit staphylococcal and enterococcal biofilm formation. Antimicrob Agents Chemother. 53:4357–4367. doi: 10.1128/AAC.00077-09.
   PubMed Web of Science ®Google Scholar
• Popova GO, Vinidchenko NN, Mikhalevich RV. 1976. Study of the effect of tetracycline, prodigiosin and their combination on the dynamics of phagocytosis of plague bacteria. Antibiotiki. 21:447–452.
   PubMedGoogle Scholar
• Roy R, Tiwari M, Donelli G, Tiwari V. 2018. Strategies for combating bacterial biofilms: a focus on anti-biofilm agents and their mechanisms of action. Virulence. 9:522–554. doi: 10.1080/21505594.2017.1313372.
   PubMed Web of Science ®Google Scholar
• Sajjad W, Ahmad S, Aziz I, Azam SS, Hasan F, Shah AA. 2018. Antiproliferative, antioxidant and binding mechanism analysis of prodigiosin from newly isolated radio-resistant Streptomyces sp. strain WMA-LM31. Mol Biol Rep. 45:1787–1798. doi: 10.1007/s11033-018-4324-3.
   PubMed Web of Science ®Google Scholar
• Shakerimoghaddam A, Razavi D, Rahvar F, Khurshid M, Ostadkelayeh SM, Esmaeili S-A, Khaledi A, Eshraghi M. 2020. Evaluate the effect of zinc oxide and silver nanoparticles on biofilm and icaA gene expression in methicillin-resistant Staphylococcus aureus isolated from burn wound infection. J Burn Care Res. 41:1253–1259. doi: 10.1093/jbcr/iraa085.
   PubMed Web of Science ®Google Scholar
• Silveira G, Go S, Torres MDT, Ribeiro CFA, Meneguetti BT, Carvalho CME, de la Fuente-Nunez C, Franco OL, Cardoso MH. 2021. Antibiofilm peptides: relevant preclinical animal infection models and translational potential. ACS Pharmacol Transl Sci. 4:55–73. doi: 10.1021/acsptsci.0c00191.
   PubMedGoogle Scholar
• Song M-J, Bae J, Lee D-S, Kim C-H, Kim J-S, Kim S-W, Hong S-I. 2006. Purification and characterization of prodigiosin produced by integrated bioreactor from Serratia sp. KH-95. J Biosci Bioeng. 101:157–161. doi: 10.1263/jbb.101.157.
   PubMed Web of Science ®Google Scholar
• Suresh MK, Biswas R, Biswas L. 2019. An update on recent developments in the prevention and treatment of Staphylococcus aureus biofilms. Int J Med Microbiol. 309:1–12. doi: 10.1016/j.ijmm.2018.11.002.
   PubMed Web of Science ®Google Scholar
• Suryawanshi RK, Patil CD, Koli SH, Hallsworth JE, Patil SV. 2017. Antimicrobial activity of prodigiosin is attributable to plasma-membrane damage. Nat Prod Res. 31:572–577. doi: 10.1080/14786419.2016.1195380.
   PubMed Web of Science ®Google Scholar
• Tsuji RF, Yamamoto M, Nakamura A, Kataoka T, Magae J, Nagai K, Yamasaki M. 1990. Selective immunosuppression of prodigiosin 25-C and FK506 in the murine immune system. J Antibiot (Tokyo). 43:1293–1301. doi: 10.7164/antibiotics.43.1293.
   PubMed Web of Science ®Google Scholar
• Vijayakumar K, Bharathidasan V, Manigandan V, Jeyapragash D. 2020. Quebrachitol inhibits biofilm formation and virulence production against methicillin-resistant Staphylococcus aureus. Microb Pathog. 149:104286. doi: 10.1016/j.micpath.2020.104286.
   PubMed Web of Science ®Google Scholar
• Wang Z, Li B, Zhou L, Yu S, Su Z, Song J, Sun Q, Sha O, Wang X, Jiang W, et al. 2016. Prodigiosin inhibits Wnt/β-catenin signaling and exerts anticancer activity in breast cancer cells. Proc Natl Acad Sci U S A. 113:13150–13155. doi: 10.1073/pnas.1616336113.
   PubMed Web of Science ®Google Scholar
• Wang B, Wei P-W, Wan S, Yao Y, Song C-R, Song P-P, Xu G-B, Hu Z-Q, Zeng Z, Wang C, et al. 2021. Ginkgo biloba exocarp extracts inhibit S. aureus and MRSA by disrupting biofilms and affecting gene expression. J Ethnopharmacol. 271:113895. doi: 10.1016/j.jep.2021.113895.
   PubMed Web of Science ®Google Scholar
• Xiang H, Cao F, Ming D, Zheng Y, Dong X, Zhong X, Mu D, Li B, Zhong L, Cao J, et al. 2017. Aloe-emodin inhibits Staphylococcus aureus biofilms and extracellular protein production at the initial adhesion stage of biofilm development. Appl Microbiol Biotechnol. 101:6671–6681. doi: 10.1007/s00253-017-8403-5.
   PubMed Web of Science ®Google Scholar
• Yin Q, Liang J, Zhang W, Zhang L, Hu Z-L, Zhang Y, Xu Y. 2019. Butenolide, a marine-derived broad-spectrum antibiofilm agent against both gram-positive and gram-negative pathogenic bacteria. Mar Biotechnol (NY). 21:88–98. doi: 10.1007/s10126-018-9861-1.
   PubMed Web of Science ®Google Scholar
• Zhang J, Shen Y, Liu J, Wei D. 2005. Antimetastatic effect of prodigiosin through inhibition of tumor invasion. Biochem Pharmacol. 69:407–414. doi: 10.1016/j.bcp.2004.08.037.
   PubMed Web of Science ®Google Scholar
• Zhang L, Wen B, Bao M, Cheng Y, Mahmood T, Yang W, Chen Q, Lv L, Li L, Yi J, et al. 2021. Andrographolide sulfonate is a promising treatment to combat methicillin-resistant Staphylococcus aureus and its biofilms. Front Pharmacol. 12:720685. doi: 10.3389/fphar.2021.720685.
   PubMed Web of Science ®Google Scholar
• Zheng D, Chen S, Cai K, Lei L, Wu C, Sun C, Deng Y, Yu C. 2021. Prodigiosin inhibits cholangiocarcinoma cell proliferation and induces apoptosis via suppressing SNAREs-dependent autophagy. Cancer Cell Int. 21:658. doi: 10.1186/s12935-021-02355-3.
   PubMed Web of Science ®Google Scholar
• Zhong H, Xie Z, Zhang S, Wei H, Song Y, Zhang Y, Wang M. 2020. Brevinin-GR23 from frog Hylarana guentheri with antimicrobial and antibiofilm activities against Staphylococcus aureus. Biosci Biotechnol Biochem. 84:143–153. doi: 10.1080/09168451.2019.1670045.
   PubMed Web of Science ®Google Scholar